US Stock MarketDetailed Quotes

Anavex Life Sciences (AVXL)

Watchlist
  • 3.340
  • +0.030+0.91%
Close Apr 24 15:59 ET
  • 3.340
  • 0.0000.00%
Post 20:01 ET
309.52MMarket Cap-7.26P/E (TTM)

Anavex Life Sciences (AVXL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-50.06%6.78M
-2.71%51.37M
-27.29%11.48M
1.63%14.31M
2.18%12.42M
19.35%13.58M
-5.27%52.8M
7.34%15.79M
8.57%14.08M
-9.58%12.15M
Selling and administrative expenses
-32.42%2.13M
25.16%13.82M
33.61%3.55M
61.17%4.5M
-9.46%2.62M
16.78%3.15M
-8.36%11.04M
2.23%2.66M
-14.04%2.79M
0.42%2.9M
-General and administrative expense
-32.42%2.13M
25.16%13.82M
33.61%3.55M
61.17%4.5M
-9.46%2.62M
16.78%3.15M
-8.36%11.04M
2.23%2.66M
-14.04%2.79M
0.42%2.9M
Research and development costs
-55.43%4.66M
-10.15%37.59M
-37.20%7.29M
-15.68%9.96M
1.68%9.89M
20.29%10.45M
-4.30%41.84M
15.45%11.61M
14.86%11.81M
-13.96%9.73M
Other operating expenses
----
50.67%-37K
-58.11%635K
71.10%-152K
79.66%-96K
---12K
-200.00%-75K
-25.98%1.52M
6.90%-526K
37.07%-472K
Operating profit
50.06%-6.78M
2.71%-51.37M
27.29%-11.48M
-1.63%-14.31M
-2.18%-12.42M
-19.35%-13.58M
5.27%-52.8M
-7.34%-15.79M
-8.57%-14.08M
9.58%-12.15M
Net non-operating interest income expense
-22.60%1.08M
-36.09%4.68M
-43.21%999K
-40.14%1.08M
-31.09%1.21M
-30.58%1.39M
31.77%7.32M
-10.16%1.76M
-1.75%1.8M
250.50%1.76M
Non-operating interest income
-22.60%1.08M
-36.09%4.68M
-43.21%999K
-40.14%1.08M
-31.09%1.21M
-30.58%1.39M
12.29%7.32M
-10.16%1.76M
-1.75%1.8M
19.86%1.76M
Non-operating interest expense
----
--0
----
----
----
----
--0
--0
--0
--0
Other net income (expense)
-46.67%40K
-87.26%316K
-72.88%653K
-116.42%-11K
107.33%11K
-89.97%75K
-7.39%2.48M
-4.90%2.41M
166.34%67K
-27.12%-150K
Gain on sale of security
102.08%7K
-275.66%-332K
-95.73%5K
-116.42%-11K
107.33%11K
-316.03%-337K
572.50%189K
162.90%117K
166.34%67K
-27.12%-150K
Other non- operating income (expenses)
-91.99%33K
-71.72%648K
----
----
----
-30.41%412K
-15.71%2.29M
-4.33%641K
3.54%585K
----
Income before tax
53.24%-5.66M
-7.85%-46.38M
15.43%-9.83M
-8.42%-13.24M
-6.16%-11.2M
-40.47%-12.11M
9.48%-43M
-13.73%-11.62M
-8.68%-12.21M
19.23%-10.55M
Income tax
18K
0
0
-93.75%-124K
-263.41%-67K
110.00%105K
Net income
53.09%-5.68M
-7.85%-46.38M
15.43%-9.83M
-8.42%-13.24M
-6.16%-11.2M
-40.47%-12.11M
9.48%-43M
-14.53%-11.62M
-8.28%-12.21M
19.54%-10.55M
Net income continuous Operations
53.09%-5.68M
-7.85%-46.38M
15.43%-9.83M
-8.42%-13.24M
-6.16%-11.2M
-40.47%-12.11M
9.48%-43M
-14.53%-11.62M
-8.28%-12.21M
19.54%-10.55M
Minority interest income
Net income attributable to the parent company
53.09%-5.68M
-7.85%-46.38M
15.43%-9.83M
-8.42%-13.24M
-6.16%-11.2M
-40.47%-12.11M
9.48%-43M
-14.53%-11.62M
-8.28%-12.21M
19.54%-10.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
53.09%-5.68M
-7.85%-46.38M
15.43%-9.83M
-8.42%-13.24M
-6.16%-11.2M
-40.47%-12.11M
9.48%-43M
-14.53%-11.62M
-8.28%-12.21M
19.54%-10.55M
Basic earnings per share
57.14%-0.06
-3.85%-0.54
21.43%-0.11
-14.29%-0.16
0.00%-0.13
-27.27%-0.14
13.33%-0.52
-7.69%-0.14
0.00%-0.14
23.53%-0.13
Diluted earnings per share
57.14%-0.06
-3.85%-0.54
21.43%-0.11
-14.29%-0.16
0.00%-0.13
-27.27%-0.14
13.33%-0.52
-7.69%-0.14
0.00%-0.14
23.53%-0.13
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -50.06%6.78M-2.71%51.37M-27.29%11.48M1.63%14.31M2.18%12.42M19.35%13.58M-5.27%52.8M7.34%15.79M8.57%14.08M-9.58%12.15M
Selling and administrative expenses -32.42%2.13M25.16%13.82M33.61%3.55M61.17%4.5M-9.46%2.62M16.78%3.15M-8.36%11.04M2.23%2.66M-14.04%2.79M0.42%2.9M
-General and administrative expense -32.42%2.13M25.16%13.82M33.61%3.55M61.17%4.5M-9.46%2.62M16.78%3.15M-8.36%11.04M2.23%2.66M-14.04%2.79M0.42%2.9M
Research and development costs -55.43%4.66M-10.15%37.59M-37.20%7.29M-15.68%9.96M1.68%9.89M20.29%10.45M-4.30%41.84M15.45%11.61M14.86%11.81M-13.96%9.73M
Other operating expenses ----50.67%-37K-58.11%635K71.10%-152K79.66%-96K---12K-200.00%-75K-25.98%1.52M6.90%-526K37.07%-472K
Operating profit 50.06%-6.78M2.71%-51.37M27.29%-11.48M-1.63%-14.31M-2.18%-12.42M-19.35%-13.58M5.27%-52.8M-7.34%-15.79M-8.57%-14.08M9.58%-12.15M
Net non-operating interest income expense -22.60%1.08M-36.09%4.68M-43.21%999K-40.14%1.08M-31.09%1.21M-30.58%1.39M31.77%7.32M-10.16%1.76M-1.75%1.8M250.50%1.76M
Non-operating interest income -22.60%1.08M-36.09%4.68M-43.21%999K-40.14%1.08M-31.09%1.21M-30.58%1.39M12.29%7.32M-10.16%1.76M-1.75%1.8M19.86%1.76M
Non-operating interest expense ------0------------------0--0--0--0
Other net income (expense) -46.67%40K-87.26%316K-72.88%653K-116.42%-11K107.33%11K-89.97%75K-7.39%2.48M-4.90%2.41M166.34%67K-27.12%-150K
Gain on sale of security 102.08%7K-275.66%-332K-95.73%5K-116.42%-11K107.33%11K-316.03%-337K572.50%189K162.90%117K166.34%67K-27.12%-150K
Other non- operating income (expenses) -91.99%33K-71.72%648K-------------30.41%412K-15.71%2.29M-4.33%641K3.54%585K----
Income before tax 53.24%-5.66M-7.85%-46.38M15.43%-9.83M-8.42%-13.24M-6.16%-11.2M-40.47%-12.11M9.48%-43M-13.73%-11.62M-8.68%-12.21M19.23%-10.55M
Income tax 18K00-93.75%-124K-263.41%-67K110.00%105K
Net income 53.09%-5.68M-7.85%-46.38M15.43%-9.83M-8.42%-13.24M-6.16%-11.2M-40.47%-12.11M9.48%-43M-14.53%-11.62M-8.28%-12.21M19.54%-10.55M
Net income continuous Operations 53.09%-5.68M-7.85%-46.38M15.43%-9.83M-8.42%-13.24M-6.16%-11.2M-40.47%-12.11M9.48%-43M-14.53%-11.62M-8.28%-12.21M19.54%-10.55M
Minority interest income
Net income attributable to the parent company 53.09%-5.68M-7.85%-46.38M15.43%-9.83M-8.42%-13.24M-6.16%-11.2M-40.47%-12.11M9.48%-43M-14.53%-11.62M-8.28%-12.21M19.54%-10.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 53.09%-5.68M-7.85%-46.38M15.43%-9.83M-8.42%-13.24M-6.16%-11.2M-40.47%-12.11M9.48%-43M-14.53%-11.62M-8.28%-12.21M19.54%-10.55M
Basic earnings per share 57.14%-0.06-3.85%-0.5421.43%-0.11-14.29%-0.160.00%-0.13-27.27%-0.1413.33%-0.52-7.69%-0.140.00%-0.1423.53%-0.13
Diluted earnings per share 57.14%-0.06-3.85%-0.5421.43%-0.11-14.29%-0.160.00%-0.13-27.27%-0.1413.33%-0.52-7.69%-0.140.00%-0.1423.53%-0.13
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More